SLRX Salarius Pharmaceuticals, Inc.

Nasdaq salariuspharma.com


$ 0.82 $ 0.00 (-0.06 %)    

Wednesday, 19-Nov-2025 09:41:37 EST
QQQ $ 599.46 $ 2.36 (0.4 %)
DIA $ 461.36 $ -0.15 (-0.03 %)
SPY $ 662.56 $ 1.80 (0.27 %)
TLT $ 89.21 $ -0.01 (-0.01 %)
GLD $ 378.41 $ 0.69 (0.18 %)
$ 0.857
$ 0.82
$ 0.80 x 5
$ 0.84 x 600
$ 0.80 - $ 0.82
$ 0.83 - $ 108.00
1,180,761
na
5.02M
$ 0.99
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-14-2025 09-30-2025 10-Q
2 08-12-2025 06-30-2025 10-Q
3 05-14-2025 03-31-2025 10-Q
4 03-21-2025 12-31-2024 10-K
5 11-14-2024 09-30-2024 10-Q
6 08-09-2024 06-30-2024 10-Q
7 05-13-2024 03-31-2024 10-Q
8 03-22-2024 12-31-2023 10-K
9 11-09-2023 09-30-2023 10-Q
10 08-10-2023 06-30-2023 10-Q
11 05-11-2023 03-31-2023 10-Q
12 03-27-2023 12-31-2022 10-K
13 11-10-2022 09-30-2022 10-Q
14 08-05-2022 06-30-2022 10-Q
15 05-12-2022 03-31-2022 10-Q
16 03-25-2022 12-31-2021 10-K
17 11-04-2021 09-30-2021 10-Q
18 08-05-2021 06-30-2021 10-Q
19 05-12-2021 03-31-2021 10-Q
20 03-18-2021 12-31-2020 10-K
21 11-12-2020 09-30-2020 10-Q
22 08-12-2020 06-30-2020 10-Q
23 05-14-2020 03-31-2020 10-Q
24 03-23-2020 12-31-2019 10-K
25 11-12-2019 09-30-2019 10-Q
26 07-17-2019 06-30-2019 10-Q
27 05-01-2019 03-31-2019 10-Q
28 03-06-2019 12-31-2018 10-K
29 11-05-2018 09-30-2018 10-Q
30 08-01-2018 06-30-2018 10-Q
31 05-02-2018 03-31-2018 10-Q
32 03-07-2018 12-31-2017 10-K
33 11-06-2017 09-30-2017 10-Q
34 08-02-2017 06-30-2017 10-Q
35 05-03-2017 03-31-2017 10-Q
36 03-08-2017 12-31-2016 10-K
37 11-02-2016 09-30-2016 10-Q
38 08-03-2016 06-30-2016 10-Q
39 05-04-2016 03-31-2016 10-Q
40 03-08-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 salarius-pharmaceuticals-says-it-became-aware-that-certain-financial-market-data-platforms-published-that-co-had-been-delisted-from-nasdaq-information-that-co-had-been-delisted-from-nasdaq-is-inaccurate

On November 17, 2025, Salarius Pharmaceuticals, Inc. (the "Company") became aware that certain financial market data pl...

 why-did-salarius-slrx-shares-soar-over-23-after-hours

Salarius Pharmaceuticals shares jumped 23.7% in after-hours trading Tuesday, closing at $1.21 following its public offering ann...

 salarius-prices-7m-public-offering-of-2514335-shares-and-pre-funded-warrants-to-purchase-2152331-shares-of-common-stock-at-a-combined-price-of-150

Salarius Pharmaceuticals, Inc. ("Salarius" or the "Company") (NASDAQ:SLRX) today announced the pricing of an un...

 salarius-pharmaceuticals-amends-merger-terms-with-decoy-to-set-1050-baseline-conversion-price-375-floor-price-for-preferred-stock

As previously disclosed, Salarius Pharmaceuticals, Inc. (the "Company") entered into an Agreement and Plan of Merger da...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION